These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24636457)

  • 1. Kaleidoscopic protein-protein interactions in the life and death of ataxin-1: new strategies against protein aggregation.
    de Chiara C; Pastore A
    Trends Neurosci; 2014 Apr; 37(4):211-8. PubMed ID: 24636457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.
    Yue S; Serra HG; Zoghbi HY; Orr HT
    Hum Mol Genet; 2001 Jan; 10(1):25-30. PubMed ID: 11136710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-protein interactions as a strategy towards protein-specific drug design: the example of ataxin-1.
    de Chiara C; Menon RP; Kelly G; Pastore A
    PLoS One; 2013; 8(10):e76456. PubMed ID: 24155902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathogenesis of spinocerebellar ataxia type 1 disease.
    Kang S; Hong S
    Mol Cells; 2009 Jun; 27(6):621-7. PubMed ID: 19572115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a self-association region within the SCA1 gene product, ataxin-1.
    Burright EN; Davidson JD; Duvick LA; Koshy B; Zoghbi HY; Orr HT
    Hum Mol Genet; 1997 Apr; 6(4):513-8. PubMed ID: 9097953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation.
    Al-Ramahi I; Lam YC; Chen HK; de Gouyon B; Zhang M; Pérez AM; Branco J; de Haro M; Patterson C; Zoghbi HY; Botas J
    J Biol Chem; 2006 Sep; 281(36):26714-24. PubMed ID: 16831871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.
    Cummings CJ; Mancini MA; Antalffy B; DeFranco DB; Orr HT; Zoghbi HY
    Nat Genet; 1998 Jun; 19(2):148-54. PubMed ID: 9620770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-chaperone CHIP promotes aggregation of ataxin-1.
    Choi JY; Ryu JH; Kim HS; Park SG; Bae KH; Kang S; Myung PK; Cho S; Park BC; Lee DH
    Mol Cell Neurosci; 2007 Jan; 34(1):69-79. PubMed ID: 17127076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.
    Klement IA; Skinner PJ; Kaytor MD; Yi H; Hersch SM; Clark HB; Zoghbi HY; Orr HT
    Cell; 1998 Oct; 95(1):41-53. PubMed ID: 9778246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic effects of expanded ataxin-1 polyglutamines with interruptions in vitro.
    Calabresi V; Guida S; Servadio A; Jodice C
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):337-42. PubMed ID: 11719269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A key lysine residue in the AXH domain of ataxin-1 is essential for its ubiquitylation.
    Kang AR; Park SH; Lee S; Choi DY; Kim KP; Song HK; Hong S; Kang S
    Biochim Biophys Acta; 2015 May; 1854(5):356-64. PubMed ID: 25641559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of S776 and 14-3-3 binding modulate ataxin-1 interaction with splicing factors.
    de Chiara C; Menon RP; Strom M; Gibson TJ; Pastore A
    PLoS One; 2009 Dec; 4(12):e8372. PubMed ID: 20037628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyglutamine is not all: the functional role of the AXH domain in the ataxin-1 protein.
    de Chiara C; Menon RP; Dal Piaz F; Calder L; Pastore A
    J Mol Biol; 2005 Dec; 354(4):883-93. PubMed ID: 16277991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions.
    Sharma D; Sharma S; Pasha S; Brahmachari SK
    FEBS Lett; 1999 Jul; 456(1):181-5. PubMed ID: 10452554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.
    Zoghbi HY; Orr HT
    J Biol Chem; 2009 Mar; 284(12):7425-9. PubMed ID: 18957430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases.
    Branco J; Al-Ramahi I; Ukani L; Pérez AM; Fernandez-Funez P; Rincón-Limas D; Botas J
    Hum Mol Genet; 2008 Feb; 17(3):376-90. PubMed ID: 17984172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembly and conformational heterogeneity of the AXH domain of ataxin-1: an unusual example of a chameleon fold.
    de Chiara C; Rees M; Menon RP; Pauwels K; Lawrence C; Konarev PV; Svergun DI; Martin SR; Chen YW; Pastore A
    Biophys J; 2013 Mar; 104(6):1304-13. PubMed ID: 23528090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of ataxin-1-like histidine insertions on polyglutamine aggregation.
    Jayaraman M; Kodali R; Wetzel R
    Protein Eng Des Sel; 2009 Aug; 22(8):469-78. PubMed ID: 19541676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors.
    Tsai CC; Kao HY; Mitzutani A; Banayo E; Rajan H; McKeown M; Evans RM
    Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4047-52. PubMed ID: 15016912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.